
Sign up to save your podcasts
Or
We love to hear from our listeners. Send us a message.
On this episode of Cell & Gene: The Podcast, Rachel Haurwitz, Ph.D., CEO at Caribou Biosciences joins Host Erin Harris to discuss the evolution of genome editing, its present state, as well as its undeniable potential. They also discuss Caribou's chRDNA genome editing technology and how it differs from CRISPR-Cas9.
Subscribe to the podcast!
Apple | Spotify | YouTube
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
On this episode of Cell & Gene: The Podcast, Rachel Haurwitz, Ph.D., CEO at Caribou Biosciences joins Host Erin Harris to discuss the evolution of genome editing, its present state, as well as its undeniable potential. They also discuss Caribou's chRDNA genome editing technology and how it differs from CRISPR-Cas9.
Subscribe to the podcast!
Apple | Spotify | YouTube
765 Listeners
807 Listeners
4,256 Listeners
32,030 Listeners
124 Listeners
271 Listeners
318 Listeners
697 Listeners
88 Listeners
31 Listeners
147 Listeners
11 Listeners
15 Listeners
149 Listeners
48 Listeners